Acarbose

Product NDC: 47781-341
11-digit product format: 477810341
Labeler code: 47781
Product ID: 47781-341_3406d658-a09f-00c1-abba-9a7a8a29786d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: acarbose
Dosage form: TABLET
Route: ORAL
Labeler: Alvogen, Inc.
Application: NDA020482
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2008-01-30
Marketing end: 2021-12-31
Substance: ACARBOSE
Active strength: 50 mg/1
Pharmacologic classes: alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
2712f130-8721-1a9d-6846-53893b13fb67	Product name	2	20210312

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
47781-341-01	EA - Each	47781-341	cb5f37b8-2145-4c8d-ae62-89a62f98ff23	1	2013-07-02

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
T58MSI464G	ACARBOSE	56180-94-0	ACARBOSE

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
199149	acarbose 50 MG Oral Tablet	PSN	4cbedeb9-d270-4e2f-8cb7-f8a8dfa4a0db	4
199149	acarbose 50 MG Oral Tablet	SCD	4cbedeb9-d270-4e2f-8cb7-f8a8dfa4a0db	4

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
47781-341-01	47781034101	100 TABLET in 1 BOTTLE (47781-341-01)	100 tablet	2015-03-12	2021-12-31	No	No	Current